Literature DB >> 16816141

Adenosine and kidney function.

Volker Vallon1, Bernd Mühlbauer, Hartmut Osswald.   

Abstract

In this review we outline the unique effects of the autacoid adenosine in the kidney. Adenosine is present in the cytosol of renal cells and in the extracellular space of normoxic kidneys. Extracellular adenosine can derive from cellular adenosine release or extracellular breakdown of ATP, AMP, or cAMP. It is generated at enhanced rates when tubular NaCl reabsorption and thus transport work increase or when hypoxia is induced. Extracellular adenosine acts on adenosine receptor subtypes in the cell membranes to affect vascular and tubular functions. Adenosine lowers glomerular filtration rate (GFR) by constricting afferent arterioles, especially in superficial nephrons, and acts as a mediator of the tubuloglomerular feedback, i.e., a mechanism that coordinates GFR and tubular transport. In contrast, it leads to vasodilation in deep cortex and medulla. Moreover, adenosine tonically inhibits the renal release of renin and stimulates NaCl transport in the cortical proximal tubule but inhibits it in medullary segments including the medullary thick ascending limb. These differential effects of adenosine are subsequently analyzed in a more integrative way in the context of intrarenal metabolic regulation of kidney function, and potential pathophysiological consequences are outlined.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16816141     DOI: 10.1152/physrev.00031.2005

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   37.312


  127 in total

1.  A2B adenosine receptor-mediated induction of IL-6 promotes CKD.

Authors:  Yingbo Dai; Weiru Zhang; Jiaming Wen; Yujin Zhang; Rodney E Kellems; Yang Xia
Journal:  J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 10.121

2.  Preserving postischemic reperfusion in the kidney: a role for extracellular adenosine.

Authors:  Joel M Weinberg; Manjeri A Venkatachalam
Journal:  J Clin Invest       Date:  2012-01-24       Impact factor: 14.808

3.  Adenosine A(2) receptors modulate tubuloglomerular feedback.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Welch
Journal:  Am J Physiol Renal Physiol       Date:  2010-06-02

Review 4.  Adenosine 2A receptors in acute kidney injury.

Authors:  I S Vincent; M D Okusa
Journal:  Acta Physiol (Oxf)       Date:  2015-05-19       Impact factor: 6.311

Review 5.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

Review 6.  Right Heart Failure and Cardiorenal Syndrome.

Authors:  Thida Tabucanon; Wai Hong Wilson Tang
Journal:  Cardiol Clin       Date:  2020-03-02       Impact factor: 2.213

Review 7.  Mechanisms of homocysteine-induced glomerular injury and sclerosis.

Authors:  Fan Yi; Pin-Lan Li
Journal:  Am J Nephrol       Date:  2007-11-07       Impact factor: 3.754

8.  Increased serum adenosine and interleukin 10 levels as new laboratory markers of increased intra-abdominal pressure.

Authors:  Zsolt Bodnár; Tamás Keresztes; Ildikó Kovács; Zoltán Hajdu; Gilbert A Boissonneault; Sándor Sipka
Journal:  Langenbecks Arch Surg       Date:  2009-12-16       Impact factor: 3.445

9.  Elevated ecto-5'-nucleotidase-mediated increased renal adenosine signaling via A2B adenosine receptor contributes to chronic hypertension.

Authors:  Weiru Zhang; Yujin Zhang; Wei Wang; Yingbo Dai; Chen Ning; Renna Luo; Kaiqi Sun; Louise Glover; Almut Grenz; Hong Sun; Lijian Tao; Wenzheng Zhang; Sean P Colgan; Michael R Blackburn; Holger K Eltzschig; Rodney E Kellems; Yang Xia
Journal:  Circ Res       Date:  2013-04-12       Impact factor: 17.367

10.  Cytoprotective effects of adenosine and inosine in an in vitro model of acute tubular necrosis.

Authors:  Katalin Módis; Domokos Gero; Nóra Nagy; Petra Szoleczky; Zoltán Dóri Tóth; Csaba Szabó
Journal:  Br J Pharmacol       Date:  2009-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.